Investor Presentaiton

Building a competitive advantage in Cell Therapy Manufacturing capacity is expanding Plan to deliver top-tier supply chain, manufacturing capacity & reliability: • Expanding drug product capacity • Strengthening vector supply • Increasing efficiency Ill Bristol Myers Squibb™ • Innovative pipeline is advancing Expanding to immunologic diseases Developing new targets Exploring innovative technologies e.g., dual binding CAR & allogeneic Well-positioned at the center of the innovation ecosystem Not for Product Promotional Use 141

View entire presentation